Multicenter phase 2 trial of nintedanib in advanced nonpancreatic neuroendocrine tumors-Reference-Cited by-同舟云学术

Multicenter phase 2 trial of nintedanib in advanced nonpancreatic neuroendocrine tumors

Published:2020-06-11 Issue:16 Volume:126 Page:3689-3697
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Iyer Renuka V.¹,Konda Bhavana²,Fountzilas Christos¹^ORCID,Mukherjee Sarbajit¹,Owen Dwight²,Attwood Kristopher³,Wang Chong³,Maguire Orla⁴,Minderman Hans⁴,Suffren Sheryl‐Ann²,Hicks Karen⁵,Wilton John⁶,Bies Robert⁶,Casucci Danielle⁵,Reidy‐Lagunes Diane⁷,Shah Manisha²

Affiliation:

1. Department of Medicine Roswell Park Comprehensive Cancer Center Buffalo New York

2. Department of Medicine The Ohio State University Comprehensive Cancer Center Columbus Ohio

3. Department of Biostatistics and Bioinformatics Roswell Park Comprehensive Cancer Center Buffalo New York

4. Flow and Image Cytometry Shared Resource Roswell Park Comprehensive Cancer Center Buffalo New York

5. Department of Clinical Research Services Roswell Park Comprehensive Cancer Center Buffalo New York

6. Department of Pharmacology and Therapeutics Roswell Park Comprehensive Cancer Center Buffalo New York

7. Department of Medicine Memorial Sloan Kettering Cancer Center New York New York

Funder

National Comprehensive Cancer Network

Boehringer Ingelheim

National Cancer Institute

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cncr.32994

Reference34 articles.

1. Exploring the rising incidence of neuroendocrine tumors: A population-based analysis of epidemiology, metastatic presentation, and outcomes

2. Lanreotide in Metastatic Enteropancreatic Neuroendocrine Tumors

3. Expression of vascular endothelial growth factor in digestive neuroendocrine tumours

4. Expression of Growth Factor Peptides and Their Receptors in Neuroendocrine Tumors of the Digestive System

5. Molecular Pathogenesis of Neuroendocrine Tumors: Implications for Current and Future Therapeutic Approaches

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. FGFR families: biological functions and therapeutic interventions in tumors;MedComm;2023-09-23

2. Tyrosine Kinase Inhibitors and Immunotherapy Updates in Neuroendocrine Neoplasms;Best Practice & Research Clinical Endocrinology & Metabolism;2023-09

3. Combination Systemic Therapies in Advanced Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs): A Comprehensive Review of Clinical Trials and Prospective Studies;Biology;2023-07-30

4. Angiogenesis in NENs, with a focus on gastroenteropancreatic NENs: from biology to current and future therapeutic implications;Frontiers in Oncology;2022-08-17

5. Advances in Targeted Therapy for Patients with Neuroendocrine Tumours;Oncology & Haematology;2022